The Translational Team Science Awards program is aimed at capitalizing on UNC-Chapel Hill’s culture of collaboration and fostering interdisciplinary teams of basic science and clinical investigators.
February 11, 2022
Paola A. Gehrig, MD, will begin her new role on June 27. She completed her residency in obstetrics and gynecology at the University of Virginia.
January 26, 2022
This research, led by Jean Cook, PhD, and Liu Mei, PhD, at the UNC School of Medicine, may help explain why certain parts of the genome become highly mutable in…
January 25, 2022
The record-setting gift supports development of innovative cancer treatments, eradicating health disparities. The center’s inaugural director is Lisa Carey, PhD, the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast…
January 20, 2022
The UNC Medical Center is the only organization in North Carolina accredited by the Commission on Cancer’s National Accreditation Program for Rectal Cancer.
December 23, 2021
Jenny Ting, PhD, is the recipient of the Illinois State University Distinguished Alumni Award for her outstanding immunology research.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious…
Announcements, Awards, Rankings and Recognitions, Bioinformatics, Cancer, Clinical Research, Covid-19 / Coronavirus, Diversity, Equity and Inclusion, Education, Events, Faculty, General Medicine, Global Health, Health Sciences, Infectious Diseases, Neurology, News, North Carolina, Oncology, Physical Medicine & Rehabilitation, Physical Therapy, Pulmonology, Research, School of Medicine, Technology and Innovation, UNC Health, Vital Signs, Wellness
October 6, 2021
$1 Million gift furthers landmark study focused on reducing breast cancer disparities, barriers to high quality care
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study.
September 29, 2021
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.
September 23, 2021
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
September 14, 2021
The UNC Lineberger Developmental Funding Program supports the development of cancer research led by faculty to stimulate new applications for extramural funding. All UNC Lineberger Comprehensive Cancer Center members, UNC-Chapel…
August 4, 2021
Tonia Poteat, PhD, MPH, a core member of the Center for Health Equity Research, and colleagues published research on delays in breast cancer care by race and sexual orientation.
July 12, 2021
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.
February 9, 2021
Dr. Rumey Ishizawar, Medical Director of the UNC Rheumatology Clinic, founded the multi-disciplinary UNC Immuno-Oncology Group (IOG) in 2017 to optimize clinical management of cancer patients who develop immune related…
February 3, 2021
Gynecologic Cancers: A Team Approach to Women’s Health Care. Please join the UNC Lineberger Cancer Network for the NC Community College lecture with Daniel Clarke-Pearson, MD, and Lyn Filip, RN,…
January 28, 2021
Linda Kelly, a 66-year-old mother of four daughters, was diagnosed with breast cancer 20 years ago and received treatment that included a mastectomy and radiation. The medical intervention saved her…
October 15, 2020
Expertscape, an online database that assesses and ranks the expertise and contributions of physicians and medical institutions worldwide, ranked Lisa Carey, MD, as one of the top 10 breast cancer…
October 1, 2020
New research by scientists at UNC Lineberger Comprehensive Cancer Center and colleagues shows the potential for targeting a specific circular RNA, known as CDR1as, to attack lung squamous cell cancer….
September 23, 2020
One in seven black women with breast cancer had delays in starting treatment, and black women also had extended duration of treatment, according to a study led by UNC Lineberger…
September 21, 2020
Family Medicine researchers receive new funding to develop first-of-its-kind health messaging on co-use of alcohol and tobacco products
A team of researchers from the UNC School of Medicine Department of Family Medicine and Lineberger Comprehensive Cancer Center have received new funding to develop and test messaging to co-users…